the epidemic is progressing in all regions of France, except Corsica

End of the lull. Public Health France announced thatThe bronchiolitis epidemic has resumed its progression in recent days after a break linked to the school holidays, in its bulletin published Wednesday, November 22. From now on, all regions of France are concerned, except Corsica.

Bronchiolitis, caused primarily by respiratory syncytial virus (RSV), causes breathing difficulties in babies. Generally not serious, it can nevertheless lead to visits to the emergency room and hospitalizations. In 2022, it was the cause of an unprecedented epidemic in more than ten years, driving tens of thousands of infants to hospital.

One of the big questions is the effect that a new preventive treatment will have, Beyfortus from Sanofi, which has met with strong support from parents to the point of being a victim of its success. Initially offered to all babies born since February, its deliveries were quickly restricted. The Minister of Health, Aurélien Rousseau, announced Sunday in The world the order of 50,000 new doses from Sanofi.